4Richard NF,Lana B.Targeted delivery,safety,and efficacy of oral enteric-coated formulations of budesonide[J].Adv Drug Del Rev,2005,57(2):303.
5Ganderton D,Lewis D,Davies R.The formulation and evaluation of a CFC-free budesonide pressurised metered dose inhaler[J].Respir Med,2003,97(Suppl D):S4.
6Vaghi A,Berg E,Liljedahl S,et al.In vitro comparison of nebulised budesonide (Pulmicort Respules(R)) and beclomethasone dipropionate (Clenil(R) per Aerosol)[J].Pulm Pharmacol Ther,2005,18(2):151.
7Warren S,Taylor G,Smith J.Gamma scintigraphic evaluation of a novel budesonide dry powder inhaler using a validated radiolabeling technique[J].J Aerosol Med,2002,15(1):15.
8Kinnarinen,T,Jarho P,Jarvinen K.Pulmonary deposition of a budesonide/γ-cyclodextrin complex in vitro[J].J Cont Rel,2003,90(2):197.
9Joshi M,Misra AN.Pulmonary disposition of budesonide from liposomal dry powder inhaler[J].Meth Find Exp Clin Pharmacol,2001,23(10):531.
10Konduri KS,Nandedkar S,Duzgunes N.Efficacy of liposomal budesonide in experimental asthma[J].J Allergy Clin Immunol,2003,111(2):321.
